|
|
 |
|
Viewing report
|
|
|
|
Antisense Therapy: Technical Aspects and Commercial Opportunities
Business Insights, March 2000
A review of the spectrum of antisense technologies reveals that considerable progress has been made during the past decade. This is more than in any other biopharmaceutical segment.
This report discusses the key antisense technologies, which have an impact on drug discovery and molecular diagnostics. Prominent among these are antisense gene therapy, ribozymes, triple helix forming oligonucleotides and peptide nucleic acid (PNA).
Customers who bought this item also bought
Gene Therapy - Technologies, Markets and Companies
Antiviral Therapeutics - Technologies, Markets and Companies
RNAi - Technologies, Markets and Companies
Cell Therapy - Technologies, Markets and Companies
Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
Nanobiotechnology Applications, Markets and Companies
Gene Therapy - Global Strategic Business Report
Animal Biotechnology - Technologies, Markets and Companies
Genetic Engineering - Global Outlook
Neuroprotection - Drugs, Markets and Companies
|
|
|
|
